Pragma Bio is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune disease. The company employs its proprietary methods in genomic sequencing, artificial intelligence, and synthetic biology to discover biomarkers and therapeutics for challenging immunologic disorders. It offers a platform that aims to aggregate public and private data in order to generate a microbiome database and leverages analytical processes to discover connections between distinct and biologically related data in order to increase statistical power and drive discovery. In addition, the platform can be used to identify novel biomarkers to risk-stratify patients and predict clinical outcomes. It was co-founded by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti in Millbrae, California in 2018.
Deep 6 AI is a computer software company that utilizes an AI-based platform that finds patients for clinical trials and it helps to provide cure to people. Its platform specializes in analyzing structured data, such as ICD-10 codes, unstructured clinical data, doctor’s notes, pathology reports, and operating notes.
Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.